CS Paper Radar

Transformer-Based Reinforcement Learning for Phase I Dose Allocation

Shijie Yuan

cs.LG stat.MLstat.AP ·submitted 2026-10-30 21:22 UTC · v1

Abstract

Phase I dose-finding trials must learn from sparse toxicity observations while limiting exposure to overly toxic doses. We develop a single reinforcement-learning policy for trials with different numbers of ordered dose levels. Each dose is represented as a token containing its normalized position, accumulated patient count, observed dose-limiting toxicities (DLTs), and current-dose indicator. A Transformer encoder summarizes the dose tokens, trial-conditioned cross-attention produces a fixed-dimensional trial representation, and a three-action policy chooses de-escalation, staying, or escalation. The final maximum tolerated dose (MTD) decision is deliberately kept outside the learned policy: after the planned sample size, weighted isotonic regression and a prespecified safety cap select the dose closest to the target toxicity probability. In the simulations, toxicity-penalized policies reduce DLT burden while unpenalized policies improve selection accuracy at the cost of greater toxicity. These results demonstrate a controllable safety--accuracy trade-off but do not establish superiority over conventional dose-finding designs.

Closest papers

Nearest neighbours by meaning across the whole index.

Adaptive Chemotherapy Control under Tumor Heterogeneity via Reinforcement Learning

cs.LG eess.SY ·2026-09-10 ·Bereket Sitotaw Kidane, Md Samiul Haque Motayed, Shuo Wang
publishedbenchmark similarity 0.69
Abstract · 6 pages. Published in the 2026 American Control Conference (ACC)

Designing effective chemotherapy regimens is hindered by tumor heterogeneity and drug resistance, which complicate the deployment of patient-specific model-based optimal control across diverse populations. We develop and compare closed-loop deep reinforcement learning (DRL) dosing policies with continuous (TD3) and discrete (DQN) action spaces trained on a high-dimensional heterogeneous tumor model. The DRL policies are benchmarked against a Pontryagin's Maximum Principle (PMP)-derived open-loop benchmark. We assess generalization under parametric heterogeneity using a 100-patient virtual cohort with plus or minus 10 percent uniform perturbations in growth and drug-sensitivity parameters. Across this cohort, TD3 achieves higher average tumor reduction, while DQN yields tighter inter-patient dosing consistency, revealing a clear efficacy-consistency trade-off in this study. Our simulations assume full observation of all tumor subpopulations; translation to sparse and noisy clinical measurements will require partial-observability formulations and/or state estimation. Overall, the results show that simulation-trained DRL can learn state-dependent feedback dosing policies that complement open-loop optimal control benchmarks.

0.33

Learning the Dose Manifold: A Latent Diffusion Framework for Volumetric Dose Prediction in Automated Radiotherapy Treatment Planning

cs.CV ·2026-10-19 ·J. Boyer-Chammard, R. Vauclin, M. C. Biston, P. Maury, M. Gau +5 more
similarity 0.65
Abstract · 27 pages, 7 figures plus graphical abstract

Automated treatment planning (ATP) aims to reduce the unwarranted inter-planner variability of manual planning, while improving treatment quality and efficiency. Most ATP pipelines rely on the prediction of the achievable three-dimensional dose distribution for a given anatomy and the subsequent optimization of machine parameters to reproduce it. Diffusion-based methods are largely slice-wise due to the high dimensionality of radiotherapy data, and assume a one-to-one mapping between anatomy and optimal dose despite the multi-objective nature of treatment planning. They are evaluated on their ability to match reference doses and rarely on their integration in ATP frameworks. We present LaDose, a latent diffusion framework for fully volumetric dose prediction. An autoencoder learned on dose distributions, trained so that perturbed latents decode to plausible doses, compresses dose maps 128-fold and enables 3D diffusion on a single GPU. Prescription values are represented as exact scalar vectors that bypass the image encoder, avoiding resampling and latent compression. Multiscale classifier-free guidance allows for the modulation of clinical trade-offs at inference, without retraining or additional labeled data. On 900 clinically delivered head-and-neck volumetric modulated arc therapy plans from five centers, LaDose reached a median absolute error of 1.18 Gy (1.4--1.8\% of the prescription) and was the only one of six frameworks free of systematic bias with respect to the reference distribution. Guidance scales acted predictably on target coverage and organ-at-risk sparing. Integrated with direct aperture optimization, the pipeline generated plans in 15.2 minutes; in a blinded review, senior clinicians rated 14 of 15 plans acceptable without editing.

0.12

Admissible Diffusion for Multimodal Interventional Trajectories

cs.LG ·2026-09-28 ·Xing Han, Shravan Chaudhari, Jiarui Shao, Paul Pu Liang, Suchi Saria
similarity 0.65
Abstract · 15 pages, 3 figures, 7 tables

Generating a plausible clinical trajectory does not establish what would happen under a different treatment. We present ADMIT, a framework combining irregular multimodal representations, treatment-conditioned latent diffusion and explicit constraints on generated states or actions. We formulate its interventional target through sequential g-computation and distinguish causal assumptions from constraint satisfaction. Its admissibility mechanism translates physiological prior knowledge into explicit constraints on generated states and proposed actions. Treatment-exposure dynamics condition latent transitions, while state projection or action gating applies the constraints during rollout so that they influence subsequent trajectory generation. In our preliminary experiments, multimodal inputs improved supervised hidden-state recovery and reduced treatment-contrast error. In a simulated dosing-schedule experiment with leak-free history encoding, ADMIT predicted most of the tumor-volume change caused by redistributing a fixed total dose. An exposure input improved these predictions around a temporary dose reduction whether or not the assumed clearance rate was correct, but reduced the predicted size of a dose effect, and a deterministic recurrent baseline matched ADMIT's average predictions. Exposure projection reduced constraint violations, although enforcement remained incomplete. Semi-synthetic experiments using eICU context illustrated treatment-response generation under fixed and adaptive policies. Observational examples further characterize model treatment sensitivity. ADMIT provides a framework for testing whether complementary observations and physiological restrictions improve intervention trajectories, with representation recovery, effect accuracy and rule enforcement assessed separately.

0.26

Conformal Policy Learning with Distribution-Free Safety Guarantees

cs.LG stat.MEecon.EMmath.ST+1 ·2026-09-15 ·Ying Jin, Naoki Egami
hot direction similarity 0.64
Abstract

Policy learning aims to determine who should be treated based on individual characteristics. In high-stakes settings such as medicine and public policy where safety is a central concern, improving the average outcomes alone may not be sufficient: decision makers may also seek to protect individuals from harm, in line with the Hippocratic principle of ``do no harm.'' In this paper, we propose \textit{conformal policy learning} (CPL), a policy learning procedure with a new distribution-free safety guarantee that controls the probability of assigning treatment to an individual who would be harmed relative to control. CPL views each treatment decision as testing a hypothesis of counterfactual harm and assigns treatment by thresholding conformal p-values. These p-values use observable proxies and selective calibration to address the challenge that the potential outcomes under comparison are never simultaneously observed. For randomized experiments, under standard exchangeability conditions, CPL provides finite-sample safety guarantee at a user-specified level, without imposing any outcome modeling assumptions. Moreover, when the outcome model is consistently estimated, CPL achieves asymptotically optimal welfare subject to the safety constraint. In observational studies, CPL with learn-then-balance weights achieves doubly robust safety guarantees. We evaluate CPL through extensive simulations and apply it to an empirical study of AI-powered interventions designed to reduce conspiracy beliefs.

0.51

LLM Detoxification via Transition-Aware Reward-Guided Representation Sampling

cs.AI ·2026-10-30 ·Aishan Liu, Yisong Xiao, Xianglong Liu, Yongxin Huang, Siyuan Liang +5 more
top venue similarity 0.63
Abstract

Large Language Models (LLMs) can generate toxic content, motivating effective test-time detoxification. Existing representation steering methods often rely on static or coarse interventions and provide imprecise guidance because they inadequately model transitions between toxic and non-toxic generations. We propose Transition-Aware Reward-Guided Representation Sampling (TARGRS), a test-time framework that learns reward guidance over toxicity transitions in latent representation space. During exploration, progressive steering along the toxicity direction constructs trajectories from non-toxic to toxic states. Toxicity scores along these trajectories turn sparse annotations into dense, listwise supervision for a transition-aware token-level reward model. During inference, TARGRS uses this model to guide coarse-to-fine sampling along the opposite, non-toxic direction: coarse sampling identifies the intervention needed to reach non-toxic regions, and refinement selects a detoxified representation with minimal perturbation. Experiments on 10 LLMs across RealToxicityPrompts, BOLD, and AttaQ show that TARGRS consistently outperforms state-of-the-art baselines, reducing toxicity by up to 69.38% on RealToxicityPrompts. TARGRS runs nearly as fast as the original LLM while preserving its core capabilities with minimal impact. By intervening in the language decoder space, TARGRS also extends to Large Vision-Language Models (LVLMs), reducing toxicity by up to 64.23% across 3 representative LVLMs.

0.31

Behavioral Cloning Outperforms Entropy-Regularized RL: Critic-Driven Failure of Actor-Critic Methods on Adaptive Tumor Treatment

cs.LG ·2026-09-06 ·Aleksandar Dimitrov, Giacomo Spigler
similarity 0.63
Abstract · 9 pages, 3 figures

Adaptive dosing requires policies that reduce tumor burden without excessive toxicity. Learned dosing policies are typically judged against historical or heuristic comparators, which cannot show whether a policy has found the best behavior available. We instead study a three-population tumor-control ODE in which optimal-control analysis fixes the form of a good schedule -- bang-bang dosing punctuated by a singular arc -- and construct a numerical controller of that form as a proxy for near-optimal behavior. Judged against this reference under a sustained-cure criterion -- 200 consecutive days below 5% carrying capacity -- Soft Actor-Critic (SAC) trained from scratch never reaches cure. Behavioral cloning (BC) of the reference reproduces it (100% sustained cure, 30/30 seeds), but SAC fine-tuning of the cloned policy destroys it across five entropy coefficients, and TD3 and BC-regularized SAC fail identically; the pattern persists under multiplicative pharmacokinetic action noise. Along curative trajectories the post-collapse critic ranks the collapsed-policy action above the reference action in 96% of states, concentrated in the maintenance phase, and the policy settles into a non-curative adaptive-therapy equilibrium. The reference is what makes this legible: against a heuristic comparator the fine-tuned policy would read as a competent controller rather than a failure.

0.29

Robust Reinforcement Learning for Dynamic Treatment Regimes under Model and Measurement Uncertainty

cs.LG ·2026-10-15 ·Chengze Xie, Xuan Wang, Ying Ding, Hairong Wang, Yan Li
similarity 0.62
Abstract

We develop a robust reinforcement learning (RL) framework for learning adaptive treatment policies that generalize across patients and remain reliable under errors in the measured biomarker and shifts in the disease dynamics. By modeling the patient as a hidden context, we address generalization and robustness in a unified manner through robust contextual Markov decision processes. Applying our framework to adaptive therapy for metastatic prostate cancer in a simulator calibrated to clinical data, we obtain generalizable and robust policies that substantially outperform the existing adaptive therapy method. In particular, we attain robustness with almost no loss of performance when the biomarker is accurate and the disease evolves as anticipated, and find that the resulting policy Pareto-dominates the existing method across a diverse array of scenarios. Our findings suggest that robust RL holds great promise as a principled methodology for learning reliable adaptive treatment policies.

0.17

Beyond Fixed Acquisition Functions: Temporal Difference Active Learning for Perturbation Discovery

cs.LG ·2026-10-15 ·Xudong Zhang, Jianzhe Li, Yitong Tang, Peijie Zhou
similarity 0.61
Abstract · 41 pages, 8 figures (including appendices)

Genetic and drug perturbation screens are important tools for elucidating disease mechanisms and validating therapeutic targets, but experimental costs limit the number of candidates that can be tested. Existing perturbation screening methods typically update the surrogate model with feedback while keeping the acquisition function fixed, limiting their ability to adapt selection to different response landscapes. Experimental feedback reveals current hits and informs subsequent selection by updating candidate predictions, providing a training signal for learning how to select experiments. We formulate budgeted perturbation discovery as a sequential decision problem and propose Temporal Difference Active Learning (TDAL), which learns an acquisition function online through temporal difference learning from a single screening trajectory, accounting for current hits and future discoveries. TDAL uses the Hellinger distance between hit probabilities for unmeasured candidates before and after an experiment to weight successor value, and reuses measured outcomes through leave-batch-out (LBO) to construct virtual transitions and alleviate training data scarcity. Across eight public screens spanning single, double, and triple perturbations under varied experimental configurations, TDAL achieves an average rank of 1.63 among eleven methods and ranks first on four tasks, demonstrating its adaptability across response landscapes.

0.27